sumadan xlt- sulfacetamide sodium, sulfur, avobenzone, octinoxate, and octisalate kit
medimetriks pharmaceuticals inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 90 mg in 1 g - sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) wash is indicated for the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) wash are contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) wash is not to be used by patients with kidney disease.
sulfacleanse 8/4- sodium sulfacetamide and sulfur lotion
prugen, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 80 mg in 1 ml - sulfacleanse® 8/4 (sodium sulfacetamide 8% & sulfur 4%) is indicated for the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sulfacleanse® 8/4 (sodium sulfacetamide 8% & sulfur 4%) is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sulfacleanse® 8/4 (sodium sulfacetamide 8% & sulfur 4%) is not to be used by patients with kidney disease.
sumadan wash- sulfacetamide sodium and sulfur cream sumadan- sulfacetamide sodium and sulfur kit
medimetriks pharmaceuticals inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 90 mg in 1 g - sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) wash is indicated for the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) wash are contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) wash is not to be used by patients with kidney disease.
sulfacetamide sodium solution
asclemed usa, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - indications and usage: sulfacetamide sodium ophthalmic solution usp, 10% is indicated for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma: escherichia coli, staphylococcus aureus, streptococcus pneumoniae, streptococcus (viridans group), haemophilus influenzae, klebsiella species, and enterobacter species. topically applied sulfonamides do not provide adequate coverage against neisseria species, serratia marcescens and pseudomonas aeruginosa . a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs. contraindications: sulfacetamide sodium ophthalmic solution is contraindicated in individuals who have a hypersensitivity to sulfonamides or to any ingredient of the preparation.
pms-sulfacetamide sod oph soln 30% drops
pharmascience inc - sulfacetamide sodium - drops - 300mg - sulfacetamide sodium 300mg - antibacterials
pms-sulfacetamide sodium liq 10% liquid
pharmascience inc - sulfacetamide sodium - liquid - 10% - sulfacetamide sodium 10% - antibacterials
sterilid-v 10% / 0.25% ophthalmic suspension
vista pharma, inc. - sulfacetamide sodium/ prednisolone acetate - ophthalmic suspension - 10% / 0.25%
sulfacetamide solution
pharma stulln inc. - sulfacetamide sodium - solution - 10% - sulfacetamide sodium 10% - antibacterials
sulfacetamide sodium solution/ drops
akorn - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms and as an adjunctive in systemic sulfonamide therapy of trachoma: escherichia coli, staphylococcus aureus, streptococcus pneumoniae, streptococcus (viridans group), haemophilus influenzae, klebsiella species, and enterobacter species. topically applied sulfonamides do not provide adequate coverage against neisseria species, serratia marcescens and pseudomonas aeruginosa . a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs. hypersensitivity to sulfonamides or to any ingredient of the preparation.
sulfacetamide sodium solution/ drops
central texas community health centers - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5) - for the treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunctive in systemic sulfonamide therapy of trachoma: escherichia coli, staphylococcus aureus, streptococcus pneumoniae, streptococcus (viridans group), haemophilus influenzae, klebsiella species, and enterobacter species. topically applied sulfonamides do not provide adequate coverage against neisseria species, serratia marcescens and pseudomonas aeruginosa . a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs. hypersensitivity to sulfonamides or to any ingredient of the preparation.